New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: A concise review

Journal of Invasive Cardiology

Volumn 27, Issue 1, 2015, Pages 41-47

  Jørgensen, Troels Højsgaard ^a   Thygesen, Julie Bjerre ^a   Thyregod, Hans Gustav Hørsted ^a   Svendsen, Jesper Hastrup ^a,b   Søndergaard, Lars ^a  

^a Departments of Cardiology Copenhagen University Hospital ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aortic valve stenosis; Atrial fibrillation; NOAF; Valvular heart disease

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIAC MONITOR; LENGTH OF STAY; NEW ONSET ATRIAL FIBRILLATION; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL MORTALITY; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; CAUSALITY; CHEMOPROPHYLAXIS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; STROKE;

AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; CAUSALITY; CHEMOPREVENTION; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84922649702     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19): 2451-2496.
2. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3): 630-634.
3. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: Literature review and clinical implications. Am Heart J. 1996;132(2 Pt 1): 408-417.
4. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17): 1597-1607.
5. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23): 2187-2198.
6. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged > or = 80 years. Eur J Cardiothorac Surg. 2006;30(5): 722-727.
7. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24): 2714-2720.
8. Amat-Santos IJ, Rodes-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(2): 178-188.
9. Saxena A, Shi WY, Bappayya S, et al. Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern? Ann Thorac Surg. 2013;95(1): 133-140.
10. Bagur R, Rodes-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5(5): 540-551.
11. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21): 2246-2280. Epub 2014 Mar 28.
12. Filardo G, Hamilton C, Hamman B, Hebeler RF Jr, Adams J, Grayburn P. New-onset postoperative atrial fibrillation and long-Term survival after aortic valve replacement surgery. Ann Thorac Surg. 2010;90(2): 474-479.
13. Motloch LJ, Reda S, Rottlaender D, et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg. 2012;93(1): 124-131.
14. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109(11): 1637-1643.
15. Roten L, Stortecky S, Scarcia F, et al. Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol. 2012;23(10): 1115-1122.
16. Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5): S45-S60.
17. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J. 2006;27(8): 949-953.
18. Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149(4): 657-663.
19. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham heart study. Circulation. 1998;98(10): 946-952.
20. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol. 1998;82(8A): 2N-9N.
21. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-Term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5): 359-364.
22. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke. 1996;27(10): 1760-1764.
23. Tu HT, Campbell BC, Christensen S, et al. Pathophysiological determinants of worse stroke outcome in atrial fibrillation. Cerebrovasc Dis. 2010;30(4): 389-395.
24. Appel CF, Hultkvist H, Nylander E, et al. Transcatheter versus surgical treatment for aortic stenosis: Patient selection and early outcome. Scand Cardiovasc J. 2012;46(5): 301-307.
25. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126(25): 3041-3053.
26. Stortecky S, Buellesfeld L, Wenaweser P, et al. Atrial fibrillation and aortic stenosis: Impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6(1): 77-84.
27. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-Analysis of complications in aortic valve replacement: Comparison of Medtronic CoreValve, Edwards Sapien, and surgical aortic valve replacement in 8536 patients. Catheter Cardiovasc Interv. 2012;80(1): 128-138.
28. Banach M, Goch A, Misztal M, Rysz J, Jaszewski R, Goch JH. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2007;134(6): 1569-1576.
29. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003;108(Suppl 1): II195-II199.
30. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1(1): 62-73.
31. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: A major morbid event? Ann Surg. 1997;226(4): 501-511; discussion, 511-503.
32. Rodes-Cabau J, Gutierrez M, Bagur R, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57(20): 1988-1999.
33. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19): 1790-1798.
34. Ruel M, Masters RG, Rubens FD, et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg. 2004;78(1): 77-83; discussion, 83-84.
35. Charitos EI, Stierle U, Ziegler PD, et al. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: Insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation. 2012;126(7): 806-814.
36. Hindricks G, Pokushalov E, Urban L, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3(2): 141-147.
37. Pecha S, Schafer T, Hartel F, et al. Concomitant surgical atrial fibrillation ablation and event recorder implantation: Better monitoring, better outcome? Interact Cardiovasc Thorac Surg. 2013;16(4): 465-469.
38. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-Analysis. Circulation. 2002;106(1): 75-80.
39. Marik PE, Fromm R. The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A systematic review. J Crit Care. 2009;24(3): 458-463.
40. Budera P, Straka Z, Osmancik P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: Final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33(21): 2644-2652.
41. Reston JT, Shuhaiber JH. Meta-Analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation. Eur J Cardiothorac Surg. 2005;28(5): 724-730.
42. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation -developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10): 1385-1413.
43. Tay EL, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4(12): 1290-1297.
44. Dewilde WJM, Oirbans T, Verheugt FWA, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet. 2013;381(9872): 1107-1115. Epub 2013 Feb 13.
45. Brennan JM, Edwards FH, Zhao Y, et al. Early anticoagulation of bioprosthetic aortic valves in older patients: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol. 2012;60(11): 971-977.
46. Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. Epub 2013 Jul 9.
47. Merie C, Kober L, Skov Olsen P, et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA. 2012;308(20): 2118-2125.
48. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12): 1139-1151.
49. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10): 883-891.
50. Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13): 1206-1214.